Asia-Pacific Countries Commit to Tackling AMR Resistance

Health leaders from countries and areas in the World Health Organization (WHO) South-East Asia and Western Pacific Regions recently sounded the alarm and committed to working together to more effectively tackle antimicrobial resistance (AMR). They endorsed a joint position paper on AMR in the human health sector in the Asia-Pacific region at an event held on the sidelines of the World Health Assembly in Geneva, Switzerland.
Initiated by the Government of Japan and endorsed by a total of 26 Asia-Pacific countries—namely, Australia, Bangladesh, Bhutan, Cambodia, Democratic People’s Republic of Korea, India, Indonesia, Japan, Lao People’s Democratic Republic, Malaysia, Maldives, Mongolia, Nauru, Nepal, New Zealand, Palau, Papua New Guinea, Philippines, Republic of Korea, Singapore, Solomon Islands, Sri Lanka, Thailand, Timor-Leste, Tonga, and Vanuatu—the joint position paper expresses the determination of leaders from these regions to accelerate action on AMR in the human health sector over the next five years.
To foster collaboration and partnership with the rest of the world, the paper will be presented at the United Nations High-Level Meeting on Antimicrobial Resistance in New York in September 2024.

Rising Threat
The misuse and overuse of antimicrobials—especially antibiotics—in humans, animals, and plants are driving the rise of drug-resistant infections. This makes common infections harder to treat and medical procedures and treatments, such as surgery and chemotherapy, much riskier. Other factors contributing to the emergence and spread of drug-resistant infections include a lack of clean water, sanitation, and hygiene (WASH) and inadequate infection prevention and control. These factors promote the spread of microbes that are resistant to treatment in health facilities and communities.
AMR is a rising threat to health and development globally, particularly in the WHO South-East Asia and Western Pacific Regions, home to nearly half of the world’s population. In 2019, AMR was the cause of an estimated 700,000 deaths in these two regions, representing more than half of the global deaths caused by AMR. Beyond the immediate threat to human health, AMR also threatens global and national economies. For instance, unless effectively addressed, countries and areas of the WHO Western Pacific Region are expected to face excess economic costs of up to US$148 billion due to AMR between 2020 and 2030.
Saima Wazed, WHO Regional Director for South-East Asia, described the agenda: “Health ministers at the World Health Assembly will discuss how to accelerate the response to AMR. By making this commitment now, and taking it to the United Nations General Assembly High-Level Meeting on AMR in September, countries from Asia and the Pacific are making clear that they recognise the urgency of action, and they are demonstrating commitment to drive change from our part of the world.”
Commitment by World Leaders
World leaders are recognising the urgency of addressing antimicrobial resistance. “To address the urgent issue of AMR, which is referred to as a ‘silent pandemic,’ we have to further accelerate international cooperation and leadership in response to it,” said Shiozaki Akihisa, Parliamentary Vice-Minister of Health, Labour and Welfare, Japan. Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific, said, “The endorsement of this joint position paper by 26 countries and areas across the Asia-Pacific region shows their determination to lead global efforts to tackle this fundamental threat to health and economies.”
In addition to endorsing the joint position paper on AMR in the human health sector in the Asia-Pacific region, the World Health Assembly will consider a resolution proposed by Thailand along with Australia, Brazil, Canada, Chile, China, Ecuador, Egypt, the European Union and its 27 Member States, Georgia, Indonesia, Japan, Kenya, Kuwait, Malaysia, Mexico, Norway, Oman, Panama, Philippines, Qatar, Saudi Arabia, South Africa, Switzerland, Thailand, the United Kingdom of Great Britain and Northern Ireland, and the United States of America. Recognising the need for a One Health approach—involving human and veterinary medicine, agriculture, aquaculture, the environment, and other sectors—the draft resolution calls on WHO, the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), and the World Organisation for Animal Health (WOAH) to continue working with member states on efforts to address AMR and to adopt the WHO strategic and operational priorities to address drug-resistant bacterial infections in the human health sector from 2025 to 2035.